REPROCELL INCORPORAT

4978
Delayed Japan Exchange - 01:00 2022-12-02 am EST
326.00 JPY +10.51%

Turn to zoom
Prev.326.00000000
Open300.00000000
High328.00000000
Low297.00000000
Volume7 609 500
Latest news
11/08
11/01
08/17
04/21
Chart REPROCELL INCORPORATED
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishBullishBullish
Resistance354373370
Spread/Res.-7,9%-13%-12%
Spread/Supp.27%27%30%
Support256256250
Financials
Sales 2023 2 630 M 19,4 M 19,4 M
Net income 2023 -170 M -1,26 M -1,26 M
Net cash 2023 4 362 M 32,2 M 32,2 M
P/E ratio 2023 -157x
Yield 2023 -
Capitalization 27 684 M 205 M 205 M
EV / Sales 2023 8,87x
EV / Sales 2024 9,00x
Nbr of Employees 98
Free-Float 94,0%
Company
ReproCELL Incorporated is primarily engaged in the development of stem cell technologies. The Company operates its business in two segments. The IPS Cell segment deals with regenerative medicine focused on Human ES (embryonic stem) cells and human iPS (induced pluripotent stem) cells. This segment...
Sector :
Biopharmaceuticals
Calendar :
2023-02-10 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 1
Last Close Price 326,00 JPY
Average target price 300,00 JPY
Spread / Average Target -7,98%